Cooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia [Corrigendum]
Wu X, Wang L, Qiu Y, Zhang B, Hu Z, Jin R. Int J Nanomedicine. 2017;12:8025–8034.On page 8025, the first affiliation was listed as “Department of Pediatrics, Union Hospital, Tongji Medical College, University of Science and Technology, Wuhan” however it should have been...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/c87834b03b324e4780656bb26a09f54b |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:c87834b03b324e4780656bb26a09f54b |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:c87834b03b324e4780656bb26a09f54b2021-12-02T03:39:53ZCooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia [Corrigendum]1178-2013https://doaj.org/article/c87834b03b324e4780656bb26a09f54b2018-01-01T00:00:00Zhttps://www.dovepress.com/corrigendum-cooperation-of-irak14-inhibitor-and-abt-737-in-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Wu X, Wang L, Qiu Y, Zhang B, Hu Z, Jin R. Int J Nanomedicine. 2017;12:8025–8034.On page 8025, the first affiliation was listed as “Department of Pediatrics, Union Hospital, Tongji Medical College, University of Science and Technology, Wuhan” however it should have been “Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China”.Read the original articleWu XWang LQiu YZhang BHu ZJin RDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 13, Pp 615-616 (2018) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine (General) R5-920 |
| spellingShingle |
Medicine (General) R5-920 Wu X Wang L Qiu Y Zhang B Hu Z Jin R Cooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia [Corrigendum] |
| description |
Wu X, Wang L, Qiu Y, Zhang B, Hu Z, Jin R. Int J Nanomedicine. 2017;12:8025–8034.On page 8025, the first affiliation was listed as “Department of Pediatrics, Union Hospital, Tongji Medical College, University of Science and Technology, Wuhan” however it should have been “Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China”.Read the original article |
| format |
article |
| author |
Wu X Wang L Qiu Y Zhang B Hu Z Jin R |
| author_facet |
Wu X Wang L Qiu Y Zhang B Hu Z Jin R |
| author_sort |
Wu X |
| title |
Cooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia [Corrigendum] |
| title_short |
Cooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia [Corrigendum] |
| title_full |
Cooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia [Corrigendum] |
| title_fullStr |
Cooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia [Corrigendum] |
| title_full_unstemmed |
Cooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia [Corrigendum] |
| title_sort |
cooperation of irak1/4 inhibitor and abt-737 in nanoparticles for synergistic therapy of t cell acute lymphoblastic leukemia [corrigendum] |
| publisher |
Dove Medical Press |
| publishDate |
2018 |
| url |
https://doaj.org/article/c87834b03b324e4780656bb26a09f54b |
| work_keys_str_mv |
AT wux cooperationofirak14inhibitorandabt737innanoparticlesforsynergistictherapyoftcellacutelymphoblasticleukemiacorrigendum AT wangl cooperationofirak14inhibitorandabt737innanoparticlesforsynergistictherapyoftcellacutelymphoblasticleukemiacorrigendum AT qiuy cooperationofirak14inhibitorandabt737innanoparticlesforsynergistictherapyoftcellacutelymphoblasticleukemiacorrigendum AT zhangb cooperationofirak14inhibitorandabt737innanoparticlesforsynergistictherapyoftcellacutelymphoblasticleukemiacorrigendum AT huz cooperationofirak14inhibitorandabt737innanoparticlesforsynergistictherapyoftcellacutelymphoblasticleukemiacorrigendum AT jinr cooperationofirak14inhibitorandabt737innanoparticlesforsynergistictherapyoftcellacutelymphoblasticleukemiacorrigendum |
| _version_ |
1718401697836957696 |